Wu JC - Search Results

1

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.

Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH. Potkin SG, et al. Among authors: wu jc. Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. doi: 10.1017/S1461145701002528. Int J Neuropsychopharmacol. 2001. PMID: 11602028 Free article. Clinical Trial.

2

A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH. Potkin SG, et al. Among authors: wu jc. Am J Psychiatry. 2002 Feb;159(2):227-37. doi: 10.1176/appi.ajp.159.2.227. Am J Psychiatry. 2002. PMID: 11823264

3

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.

Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE Jr, Fallon JH, Kennedy JL. Potkin SG, et al. Among authors: wu jc. Mol Psychiatry. 2003 Jan;8(1):109-13. doi: 10.1038/sj.mp.4001191. Mol Psychiatry. 2003. PMID: 12556915 Clinical Trial.

4

Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep.

Wu JC, Gillin JC, Buchsbaum MS, Chen P, Keator DB, Khosla Wu N, Darnall LA, Fallon JH, Bunney WE. Wu JC, et al. Neuropsychopharmacology. 2006 Dec;31(12):2783-92. doi: 10.1038/sj.npp.1301166. Epub 2006 Jul 26. Neuropsychopharmacology. 2006. PMID: 16880772

5

Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression.

Wu JC, Gillin JC, Buchsbaum MS, Schachat C, Darnall LA, Keator DB, Fallon JH, Bunney WE. Wu JC, et al. J Affect Disord. 2008 Apr;107(1-3):181-6. doi: 10.1016/j.jad.2007.07.030. Epub 2007 Nov 26. J Affect Disord. 2008. PMID: 18031825

6

Increased dopamine activity associated with stuttering.

Wu JC, Maguire G, Riley G, Lee A, Keator D, Tang C, Fallon J, Najafi A. Wu JC, et al. Neuroreport. 1997 Feb 10;8(3):767-70. doi: 10.1097/00001756-199702100-00037. Neuroreport. 1997. PMID: 9106763

7

D2 dopamine receptor polymorphism and brain regional glucose metabolism.

Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. Noble EP, et al. Among authors: wu jc. Am J Med Genet. 1997 Apr 18;74(2):162-6. Am J Med Genet. 1997. PMID: 9129716

8

Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.

Wu JC, Bell K, Najafi A, Widmark C, Keator D, Tang C, Klein E, Bunney BG, Fallon J, Bunney WE. Wu JC, et al. Neuropsychopharmacology. 1997 Dec;17(6):402-9. doi: 10.1016/S0893-133X(97)00089-4. Neuropsychopharmacology. 1997. PMID: 9397428 Clinical Trial.

9

Correlation of intellectual impairment in Parkinson's disease with FDG PET scan.

Wu JC, Iacono R, Ayman M, Salmon E, Lin SD, Carlson J, Keator D, Lee A, Najafi A, Fallon J. Wu JC, et al. Neuroreport. 2000 Jul 14;11(10):2139-44. doi: 10.1097/00001756-200007140-00016. Neuroreport. 2000. PMID: 10923659

10

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

Schroder J, Buchsbaum MS, Siegel BV, Geider FJ, Lohr J, Tang C, Wu J, Potkin SG. Schroder J, et al. Schizophr Res. 1996 Mar;19(1):41-53. doi: 10.1016/0920-9964(95)00043-7. Schizophr Res. 1996. PMID: 9147495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,459 results

Search Page

Filters